Louisiana State Employees Retirement System Krystal Biotech, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.33 Billion
- Q3 2024
A detailed history of Louisiana State Employees Retirement System transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 12,200 shares of KRYS stock, worth $2.17 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,200
Previous 12,500
2.4%
Holding current value
$2.17 Million
Previous $2.3 Million
3.36%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.4MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$703 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$508 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$467 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$259 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$176 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.57B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...